National Council for Prescription Drug Programs indexing - billing unit
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Label type
- Indexing - Billing Unit
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 02:36:37
Label at a glance#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66621-0150-1 | EA - Each | 66621-0150 | c1b5574c-e204-4436-8ecb-4d6e932832ec | 1 | 2012-07-24 |
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 66621-0150 | 66621-0150-1 |
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125335 | Anascorp | Centruroides (Scorpion) Immune F(ab')2 (Equine) Injection | 351(a) | Rx | 2026-10-01 |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ANASCORP | CENTRUROIDES (SCORPION) IMMUNE F(AB)2 (EQUINE) | Rare Disease Therapeutics, Inc | 5cb65048-a30c-48e5-8bc8-897983d08068 | 2025-07-16 | Warnings, Adverse reactions | 66621-0150-1 66621015001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.